^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ELC-301

    i
    Other names: ELC-301, ELC301, ELC 301
    Associations

    News

    Trials
    Company:
    Elicera Therap
    Drug class:
    CD20-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    6ms
    CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study) (clinicaltrials.gov)
    P1/2, N=18, Recruiting, Uppsala University | Not yet recruiting --> Recruiting
    Enrollment open
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    cyclophosphamide • fludarabine IV • ELC-301